For people with UC, ‘feeling better’ is just the start. Learn why tissue-level (histological) healing is becoming the new ...

A case report review examined complications, diagnosis, and treatment of genital Crohn's disease, a rare extraintestinal ...

Ulcerative colitis (UC) is a chronic, immune-mediated inflammatory disorder of the colon that follows a relapsing-remitting course. Characterised by mucosal inflammation, the disease requires accurate ...

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative ...

Switching UC treatments while managing a career and home life can be a major challenge. Here’s how to navigate work logistics ...

T he goal of ulcerative colitis (UC) treatment is twofold: to heal the inflamed mucosal lining of the gut and to eliminate symptoms such as cramping and pain (usually once the inflammation subsides).

Pivotal Phase 3 global KEPLER study of vedolizumab intravenous (IV) in pediatric patients ages 2 to 17, who had an inadequate response to either conventional treatment options or tumor necrosis factor ...

The Department of Defense is tapping a research team led by Mount Sinai to study a novel treatment for ulcerative colitis, an enemy within that disproportionately impacts individuals in the military.

SHANGHAI, Feb. 6, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and ...